Characterization of autoimmune eye disease in association with Down's syndrome.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
19 Aug 2023
19 Aug 2023
Historique:
received:
01
04
2023
accepted:
10
08
2023
revised:
30
07
2023
medline:
20
8
2023
pubmed:
20
8
2023
entrez:
19
8
2023
Statut:
aheadofprint
Résumé
Autoimmunity and deficiency of the transcription factor autoimmune regulator protein (AIRE) are known associations with Down syndrome (DS). Lack of AIRE abrogates thymic tolerance. The autoimmune eye disease associated with DS has not been characterized. We identified a series of subjects with DS (n = 8) and uveitis. In three consecutive subjects, we tested the hypothesis that autoimmunity to retinal antigens might be a contributing factor. This was a multicentred, retrospective case series. Deidentified clinical data of subjects with both DS and uveitis were collected via questionnaire by uveitis-trained ophthalmologists. Anti-retinal autoantibodies (AAbs) were detected using an Autoimmune Retinopathy Panel tested in the OHSU Ocular Immunology Laboratory. We characterized eight subjects (mean age 29 [range, 19-37] years). The mean age of detected uveitis onset was 23.5 [range, 11-33] years. All eight subjects had bilateral uveitis (p < 0.001 based on comparison to published university referral patterns), with anterior and intermediate uveitis found in six and five subjects respectively. Each of three subjects tested for anti-retinal AAbs was positive. Detected AAbs included anti-carbonic anhydrase II, anti-enolase, anti-arrestin, and anti-aldolase. A partial deficiency in the AIRE on chromosome 21 has been described in DS. The similarities in the uveitis presentations within this patient group, the known autoimmune disease predisposition in DS, the recognized association of DS and AIRE deficiency, the reported detection of anti-retinal antibodies in patients with DS in general, and the presence of anti-retinal AAbs in three subjects in our series supports a causal association between DS and autoimmune eye disease.
Sections du résumé
BACKGROUND
BACKGROUND
Autoimmunity and deficiency of the transcription factor autoimmune regulator protein (AIRE) are known associations with Down syndrome (DS). Lack of AIRE abrogates thymic tolerance. The autoimmune eye disease associated with DS has not been characterized. We identified a series of subjects with DS (n = 8) and uveitis. In three consecutive subjects, we tested the hypothesis that autoimmunity to retinal antigens might be a contributing factor.
SUBJECTS/METHODS
METHODS
This was a multicentred, retrospective case series. Deidentified clinical data of subjects with both DS and uveitis were collected via questionnaire by uveitis-trained ophthalmologists. Anti-retinal autoantibodies (AAbs) were detected using an Autoimmune Retinopathy Panel tested in the OHSU Ocular Immunology Laboratory.
RESULTS
RESULTS
We characterized eight subjects (mean age 29 [range, 19-37] years). The mean age of detected uveitis onset was 23.5 [range, 11-33] years. All eight subjects had bilateral uveitis (p < 0.001 based on comparison to published university referral patterns), with anterior and intermediate uveitis found in six and five subjects respectively. Each of three subjects tested for anti-retinal AAbs was positive. Detected AAbs included anti-carbonic anhydrase II, anti-enolase, anti-arrestin, and anti-aldolase.
DISCUSSION
CONCLUSIONS
A partial deficiency in the AIRE on chromosome 21 has been described in DS. The similarities in the uveitis presentations within this patient group, the known autoimmune disease predisposition in DS, the recognized association of DS and AIRE deficiency, the reported detection of anti-retinal antibodies in patients with DS in general, and the presence of anti-retinal AAbs in three subjects in our series supports a causal association between DS and autoimmune eye disease.
Identifiants
pubmed: 37598261
doi: 10.1038/s41433-023-02706-6
pii: 10.1038/s41433-023-02706-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© 2023. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Références
Agarwal Gupta N, Kabra M. Diagnosis and management of Down syndrome. Indian J Pediatr. 2014;81:560–7.
doi: 10.1007/s12098-013-1249-7
pubmed: 24127006
Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down’s syndrome. Lancet. 2000;355:165–9.
doi: 10.1016/S0140-6736(99)05264-2
pubmed: 10675114
Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancers and immune related diseases associated with Down’s syndrome: a record linkage study. Arch Dis Child. 2004;89:1014–7.
doi: 10.1136/adc.2003.046219
pubmed: 15499053
pmcid: 1719725
Van Goor JC, Massa GG, Hirasing R. Increased incidence and prevalence of diabetes mellitus in Down’s syndrome. Arch Dis Child. 1997;77:186.
pubmed: 9301372
Bergholdt R, Eising S, Nerup J, Pociot F. Increased prevalence of Down’s syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study. Diabetologia. 2006;49:1179–82.
doi: 10.1007/s00125-006-0231-6
pubmed: 16575558
Bonamico M, Pasquino AM, Mariani P, Danesi HM, Culasso F, Mazzanti L, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 2002;87:5495–8.
doi: 10.1210/jc.2002-020855
pubmed: 12466343
Gale L, Wimalaratna H, Brotodiharjo A, Duggan JM. Down’s syndrome is strongly associated with coeliac disease. Gut. 1997;40:492–6.
doi: 10.1136/gut.40.4.492
pubmed: 9176077
pmcid: 1027124
Mårild K, Stephansson O, Grahnquist L, Cnattingius S, Söderman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013;163:237–42.
doi: 10.1016/j.jpeds.2012.12.087
pubmed: 23399451
Cebeci AN, Guven A, Yildiz M. Profile of hypothyroidism in Down’s syndrome. J Clin Res Pediatr Endocrinol. 2013;5:116–20.
doi: 10.4274/Jcrpe.884
pubmed: 23748065
pmcid: 3701917
Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, et al. Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol. 2012;169:238–43.
doi: 10.1111/j.1365-2249.2012.04610.x
pubmed: 22861363
pmcid: 3445000
Foley CM, Deely DA, MacDermott EJ, Killeen OG. Arthropathy of Down syndrome: an under-diagnosed inflammatory joint disease that warrants a name change. RMD Open. 2019;5:e000890.
doi: 10.1136/rmdopen-2018-000890
pubmed: 31245048
pmcid: 6560675
Foley C, Killeen OG. Musculoskeletal anomalies in children with Down syndrome: an observational study. Arch Dis Child. 2019;104:482–7.
doi: 10.1136/archdischild-2018-315751
pubmed: 30472668
Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91:2843–50.
doi: 10.1210/jc.2005-2611
pubmed: 16684821
Giménez-Barcons M, Casteràs A, Armengol Mdel P, Porta E, Correa PA, Marín A, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. J Immunol. 2014;193:3872–9.
doi: 10.4049/jimmunol.1400223
pubmed: 25217160
Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, Philippot Q, Buta S, et al. Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c(+) B cells. Nature. 2023;615:305–14.
doi: 10.1038/s41586-023-05736-y
pubmed: 36813963
pmcid: 9945839
Plössl K, Straub K, Schmid V, Strunz F, Wild J, Merkl R, et al. Identification of the retinoschisin-binding site on the retinal Na/K-ATPase. PLoS One. 2019;14:e0216320.
doi: 10.1371/journal.pone.0216320
pubmed: 31048931
pmcid: 6497308
Ugurlu A, Altinkurt E. Ophthalmologic manifestations and retinal findings in children with Down syndrome. J Ophthalmol. 2020;2020:9726261.
doi: 10.1155/2020/9726261
pubmed: 32089873
pmcid: 7029299
Fong AH, Shum J, Ng AL, Li KK, McGhee S, Wong D. Prevalence of ocular abnormalities in adults with Down syndrome in Hong Kong. Br J Ophthalmol. 2013;97:423–8.
doi: 10.1136/bjophthalmol-2012-302327
pubmed: 23376568
van Splunder J, Stilma JS, Bernsen RM, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology. 2004;111:1457–63.
doi: 10.1016/j.ophtha.2003.12.051
pubmed: 15288971
Mangalesh S, Vinekar A, Jayadev C, Kemmanu V, Bhat M, Sivakumar M, et al. Spectral domain optical coherence tomography in detecting sub-clinical retinal findings in Asian Indian children with Down syndrome. Curr Eye Res. 2019;44:901–7.
doi: 10.1080/02713683.2019.1597128
pubmed: 30961422
Adamus G, Champaigne R, Yang S. Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy. Clin. Immunol. 2020;210:108317.
doi: 10.1016/j.clim.2019.108317
pubmed: 31770612
Adamus G. Current techniques to accurately measure anti-retinal autoantibodies. Expert Rev Ophthalmol. 2020;15:111–8.
doi: 10.1080/17469899.2020.1739522
pubmed: 32318114
pmcid: 7172387
Sen ES, Ramanan AV, Rosenbaum JT. Uveitis in Juvenile Idiopathic Arthritis. Ch. 22. In: Petty RE, et al. editors. Textbook of pediatric rheumatology. Philadelphia, PA: Elsevier; 2021. p. 279–93.
Jones JT, Kitchen J, Talib N. Down syndrome-associated arthritis (DA): diagnostic and management challenges. Pediatric Health Med Ther. 2022;13:53–62.
doi: 10.2147/PHMT.S282646
pubmed: 35311022
pmcid: 8932915
McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297.
doi: 10.1371/journal.pmed.0030297
pubmed: 16942393
pmcid: 1564298
Huggard D, Kelly L, Ryan E, McGrane F, Lagan N, Roche E, et al. Increased systemic inflammation in children with Down syndrome. Cytokine. 2020;127:154938.
doi: 10.1016/j.cyto.2019.154938
pubmed: 31785499
McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol. 1996;121:35–46.
doi: 10.1016/S0002-9394(14)70532-X
pubmed: 8554079
Huggard D, Doherty DG, Molloy EJ. Immune dysregulation in children with Down syndrome. Front Pediatr. 2020;8:73.
doi: 10.3389/fped.2020.00073
pubmed: 32175298
pmcid: 7056667
Zhang Y, Che M, Yuan J, Yu Y, Cao C, Qin XY, et al. Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis. Oncotarget. 2017;8:84489–96.
doi: 10.18632/oncotarget.21060
pubmed: 29137441
pmcid: 5663613
DeVoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med. 2006;203:2727–35.
doi: 10.1084/jem.20061864
pubmed: 17116738
pmcid: 2118158
de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Med. 2017;19:439–47.
doi: 10.1038/gim.2016.127
pubmed: 27608174
Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491–500.
doi: 10.1016/j.ophtha.2003.06.014
pubmed: 15019324
Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266.
doi: 10.1016/j.coi.2022.102266
pubmed: 36446151
Wen X, Li B. A population-based study on autoimmune disease. Lancet. 2023;401:1829–31.
doi: 10.1016/S0140-6736(23)00621-9
pubmed: 37156254